Related Experiment Videos
Rubella embryopathy after previous maternal rubella vaccination
Insights
A vaccinated mother transmitted congenital rubella infection to her infant, despite previous Cendehill vaccination. This case highlights the potential for vaccine-induced immunity to wane, risking intrauterine infection upon re-exposure.
Area of Science:
- Virology
- Immunology
- Pediatrics
Background:
- Congenital rubella infection (CRI) can cause severe developmental abnormalities.
- Rubella vaccination aims to prevent both maternal and fetal infection.
- Maternal immunity duration and effectiveness against intrauterine transmission require ongoing evaluation.
Observation:
- A male infant presented with classical and expanded rubella syndrome.
- The infant's mother had received Cendehill rubella vaccine seven years prior to conception.
- The infant succumbed to the infection at 8.5 months of age.
Findings:
- Rubella embryopathy was confirmed via rubella-specific IgM antibodies and persistent HAI/IgG antibodies.
- Rubella virus was isolated from the infant's throat secretions, urine, and blood mononuclear cells.
- This case demonstrates a failure of vaccine-induced immunity to prevent intrauterine rubella transmission.
Implications:
- This case questions the long-term protective efficacy of rubella vaccines against congenital infection.
- It underscores the need to investigate antibody persistence and booster vaccination strategies.
- Understanding waning immunity is crucial for preventing rubella embryopathy in infants.
Abstract:
This report concerns a boy with congenital rubella infection and features of the classical and expanded rubella syndrome who was born to a mother who had been successfully vaccinated with Cendehill vaccine seven years previously. The diagnosis of rubella embryopathy was confirmed by demonstrating rubella-specific serum IgM antibodies using four different methods, by the persistence of rubella HAI and IgG antibodies in serum taken between three and eight months of age and by the isolation of rubella virus from throat secretion, urine and blood mononuclear cells. The child died at eight-and-a-half months of age. This case is discussed in relation to the persistence of vaccine-induced immunity with particular respect to the protective quality of low levels of antibodies against intrauterine infection in the event of re-infection during pregnancy.